PureTech Health plc
PRTC.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £4 | £1 | £2 | £10 |
| % Growth | 475.3% | -64.1% | -79.1% | – |
| Cost of Goods Sold | £0 | £94 | £152 | £110 |
| Gross Profit | £4 | -£93 | -£137 | -£100 |
| % Margin | 100% | -12,387.3% | -6,546.2% | -1,007% |
| R&D Expenses | £54 | £96 | £116 | £82 |
| G&A Expenses | £27 | £25 | £36 | £31 |
| SG&A Expenses | £27 | £25 | £36 | £31 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £59 | -£68 | -£91 | -£55 |
| Operating Expenses | £140 | £53 | £61 | £57 |
| Operating Income | -£136 | -£146 | -£198 | -£150 |
| % Margin | -3,154% | -19,493.2% | -9,464.4% | -1,506% |
| Other Income/Exp. Net | £160 | £110 | £105 | £91 |
| Pre-Tax Income | £24 | -£36 | -£93 | -£59 |
| Tax Expense | -£4 | £31 | -£56 | £4 |
| Net Income | £54 | -£66 | -£50 | -£61 |
| % Margin | 1,240.1% | -8,759.6% | -2,409.3% | -606.9% |
| EPS | 0.2 | -0.24 | -0.18 | -0.21 |
| % Growth | 183.3% | -33.3% | 14.3% | – |
| EPS Diluted | 0.2 | -0.24 | -0.18 | -0.21 |
| Weighted Avg Shares Out | 270 | 274 | 280 | 287 |
| Weighted Avg Shares Out Dil | 270 | 276 | 285 | 287 |
| Supplemental Information | – | – | – | – |
| Interest Income | £23 | £16 | £6 | £0 |
| Interest Expense | £10 | £13 | £4 | £5 |
| Depreciation & Amortization | £4 | £5 | £9 | £7 |
| EBITDA | £37 | -£18 | -£80 | -£47 |
| % Margin | 866.3% | -2,357.5% | -3,824.7% | -470.5% |